A Phase 2, Double-blind, Parallel Group, Randomised, Placebo Controlled, Proof of Concept Study to Assess the Safety and Efficacy of OBE001 After Oral Administration in Pregnant Women With Threatened Preterm Labour

Trial Profile

A Phase 2, Double-blind, Parallel Group, Randomised, Placebo Controlled, Proof of Concept Study to Assess the Safety and Efficacy of OBE001 After Oral Administration in Pregnant Women With Threatened Preterm Labour

Discontinued
Phase of Trial: Phase II

Latest Information Update: 08 Nov 2017

At a glance

  • Drugs Nolasiban (Primary)
  • Indications Preterm labour
  • Focus Proof of concept; Therapeutic Use
  • Acronyms TERM
  • Sponsors ObsEva
  • Most Recent Events

    • 17 Jan 2017 Status changed from active, no longer recruiting to discontinued due to Enrolment difficulties.
    • 15 Jan 2017 This trial was completed in Belgium, according to European Clinical Trials Database.
    • 13 Dec 2016 This trial was completed in Poland (end date: 2016-10-28), according to European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top